Patents Assigned to AYANDA AS
-
Publication number: 20170105992Abstract: This invention provides an oral veterinary pharmaceutical or nutraceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion further comprising at least one component selected from taste enhancers, odour enhancers, digestive enzymes and veterinary drugs.Type: ApplicationFiled: December 27, 2016Publication date: April 20, 2017Applicant: AYANDA GROUP ASInventors: Kurt Ingar DRAGET, Ingvild Johanne HAUG, Steinar Johan ENGELSEN, Tore SETERNES
-
Patent number: 9539205Abstract: The invention relates to an orally administrable chewable composition in unit dosage form comprising an oil-in-water emulsion in which the aqueous phase is gelled and in which the oil phase comprises a physiologically tolerable unsaturated fatty acid ester.Type: GrantFiled: January 25, 2007Date of Patent: January 10, 2017Assignee: AYANDA GROUP ASInventors: Ingvild Haug, Kurt Ingar Draget
-
Publication number: 20140163108Abstract: The invention provides an oral pharmaceutical composition, optionally in dose unit form, comprising a lipophilic drug substance in dispersion in a physiologically tolerable aqueous carrier, preferably an aqueous gel, wherein said drug substance contains a functional electrostatic group having a pKa value of from 2 to 10, characterised in that said aqueous carrier has a pH at least 0.3 below or above said pKa value, said pH being below said pKa where said group is acidic and above said pKa where said group is basic.Type: ApplicationFiled: October 19, 2011Publication date: June 12, 2014Applicant: AYANDA GROUP ASInventors: Kurt Ingar Draget, Steinar Johan Engelsen, Tore Seternes, Magnus Hattrem, Ingvild Johanne Haug
-
Publication number: 20140065192Abstract: The invention relates to an orally administrable, sour-tasting chewable composition in unit dosage form comprising an oil-in-water emulsion in which the aqueous phase is gelled and comprises at least one physiologically acceptable acid and at least one buffering agent and in which the oil phase comprises a physiologically tolerable unsaturated fatty acid ester.Type: ApplicationFiled: October 6, 2011Publication date: March 6, 2014Applicant: AYANDA GROUP ASInventor: Andrzej Siwek
-
Publication number: 20140005179Abstract: The invention provides an oral pharmaceutical composition, optionally in dose unit form, comprising a lipophilic drug substance in dispersion in a physiologically tolerable aqueous carrier, preferably an aqueous gel, wherein said drug substance contains a functional electrostatic group having a pKa value of from 2 to 10, characterised in that said aqueous carrier has a pH at least 0.3 below or above said pKa value, said pH being below said pKa where said group is acidic and above said pKa where said group is basic.Type: ApplicationFiled: April 11, 2011Publication date: January 2, 2014Applicant: AYANDA GROUP ASInventors: Kurt Ingar Draget, Ingvild Haug, Magnus N. Hattrem, Tore Seternes, Steinar Johan Engelsen
-
Publication number: 20130280317Abstract: This invention provides oral nutraceutical or pharmaceutical compositions comprising a physiologically tolerable capsule provided with a chewing or bubble gum coat (preferably a chewing gum coat) and containing a physiologically tolerable lipid.Type: ApplicationFiled: May 13, 2011Publication date: October 24, 2013Applicant: AYANDA GROUP ASInventor: Jan Erik Olsen
-
Publication number: 20130273025Abstract: This invention provides an oral veterinary pharmaceutical or nutraceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion further comprising at least one component selected from taste enhancers, odour enhancers, digestive enzymes and veterinary drugs.Type: ApplicationFiled: April 11, 2011Publication date: October 17, 2013Applicant: AYANDA GROUP ASInventors: Kurt Ingar Draget, Ingvild Johanne Haug, Steinar Johan Engelsen, Tore Seternes
-
Publication number: 20130273152Abstract: This invention provides an oral pharmaceutical composition comprising a physiologically tolerable shell containing a drug of abuse within an oil comprising physiologically tolerable unsaturated fatty acids.Type: ApplicationFiled: April 11, 2011Publication date: October 17, 2013Applicant: AYANDA GROUP ASInventors: Kurt Ingar Draget, Ingvild Johanne Haug, Steinar Johan Engelsen, Tore Seternes
-
Publication number: 20130274280Abstract: This invention provides an oral pharmaceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion containing a drug of abuse.Type: ApplicationFiled: April 11, 2011Publication date: October 17, 2013Applicant: AYANDA GROUP ASInventors: Kurt Ingar Draget, Ingvild Johanne Haug, Steinar Johan Engelsen, Tore Seternes, Magnus N. Hattrem
-
Publication number: 20130217047Abstract: The present invention relates to a method for the accurate, rapid and sensitive detection of breast or ovarian cancers from body fluid samples of a mammalian subject and related assay, kits and peptides suitable for such a method.Type: ApplicationFiled: September 23, 2011Publication date: August 22, 2013Applicant: AYANDA BIOSYSTEMS SAInventors: Solomzi Makohliso, Irmgard Irminger-Finger, Fernando Herrera
-
Publication number: 20110045067Abstract: The invention relates to soft gelatin capsules containing at least one pharmaceutical, wherein the capsule shell includes carrageenan and cold water fish gelatin or a mixture of cold fish gelatin and warm fish gelatin.Type: ApplicationFiled: January 29, 2009Publication date: February 24, 2011Applicant: AYANDA ASInventors: Ingvild Johanne Haug, Kurt Ingar Draget
-
Publication number: 20100322995Abstract: The invention relates to a fish food capsule, comprising a capsule casing and a liquid or suspension-like fish food product enclosed in the capsule casing, wherein a gas phase determining the buoyancy of the fish food capsule is provided in the fish food capsule, and to the use thereof, a fish food kit, and a method for producing the fish food capsule.Type: ApplicationFiled: October 16, 2008Publication date: December 23, 2010Applicant: AYANDA GMBH & CO. KG, FALKENHAGENInventor: Jens Geselle
-
Publication number: 20100016228Abstract: The invention concerns a novel polypeptide derived from the cleavage of the BARD1 protein, a nucleic acid encoding for said polypeptide, and their diagnostic and therapeutic uses, in particular for treating tumors.Type: ApplicationFiled: June 23, 2009Publication date: January 21, 2010Applicant: Ayanda Biosystems SAInventors: FABIEN GAUTIER, Jean Harb, Khaled Meflah, Irmgard Irminger-Finger
-
Patent number: 7566764Abstract: The invention concerns a novel polypeptide derived from the cleavage of the BARD1 protein, a nucleic acid coding for said polypeptide, and their diagnostic and therapeutic uses, in particular for treating tumours.Type: GrantFiled: September 3, 2001Date of Patent: July 28, 2009Assignee: Ayanda Biosystems SAInventors: Fabien Gautier, Jean Harb, Khaled Meflah, Irmgard Irminger-Finger